Meine Zukunft Innovative Chemie Interviews Inspirierende Job-Links Meine Ausbildung

Research Institute of Molecular Pathologie

Firmenlogo

The Research Institute of Molecular Pathology (IMP) is part of the internationally operating pharmaceutical company Boehringer Ingelheim. Set up in 1988 in Vienna's 3rd district (Landstrasse), the Institute became the center of a biomedical campus which today enjoys a world-wide reputation as "The Vienna
Biocenter". IMP is exclusively conducting basic research. Almost 200 scientists concentrate on questions from the field of cell development and molecular genetics.

News Focussing on Members

(AVIR Green Hills Biotechnology AG) deltaFLU –innovative vaccines for intranasal spray delivery or oral administration more 

 

(Apeptico) APEPTICO Announces Successful Completion of Phase I Trial with AP301 in Oedematous Respiratory Failure  more 

 

(Intercell) Intercell announces new management structure more 

 

(Eucodis) EUCODIS Bioscience and evocatal enter into alliance more 

 

(Intercell) Staph Bakali new Chief Business Officer more 

 

(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases more 

 

(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 more